Pure Global
NCT05906381

Dry Eye Symptom Mitigation by Oral Intake of Probiotics

A Clinical Trial of Dry Eye Symptom Mitigation by Oral Intake of Probiotics
Chung Shan Medical University·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Dry Eye
Drug/Device/Intervention
Probiotics
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Chung Shan Medical University
Location
Taichung, Taiwan
Timeline & enrollment
Phase
N/A
Start date
May 13, 2023
End date
Dec 31, 2023
Enrollment
88 participants
Primary outcome

Change of Schirmer's Test Value from Baseline,Change of Tear Film Breakup Time from Baseline,Ocular Surface Index Change from Baseline,Tear Osmolality Change from Baseline,Serum Biochemical Test

Summary

This study investigates whether the oral intake of a probiotics capsule product may relieve
 dry eye symptoms. Participants will be aged between 20 - 65 years of age, with confirmed
 diagnosis of dry eye status. The participants will be assessed for several parameters and
 asked to take 1 probiotics capsule per day for 35 days. The parameters will include ocular
 surface health, tear volume, tear quality, intraocular pressure, tear osmolarity and serum
 biochemical test. After the 35 days are completed, the participants will be assessed again
 for the same parameters.

ICD-10 classifications
Ocular painAvulsion of eyeOther corneal deformitiesCorneal ulcerDry mouth, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05906381
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05906381 through Pure Global AI's free database. This phase not specified trial is sponsored by Chung Shan Medical University and is currently Recruiting. The study focuses on Dry Eye. Target enrollment is 88 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.